Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker IMRX
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 23, 2026 | Benjamin J. Zeskind PRESIDENT AND CEO, Director | IMRX Immuneering Corporation | Buy | 2,400 | $4.56 | $10.9K Buy | Form 4 ↗ |
| Jun 15, 2026 | Brett Matthew Hall CHIEF SCIENTIFIC OFFICER | IMRX Immuneering Corporation | Buy | 6,035 | $4.15 | $25.0K Buy | Form 4 ↗ |
| Jan 16, 2026 | Harold Eugene Brakewood Chief Business Officer | IMRX Immuneering Corporation | Buy | 5,250 | $4.76 | $25.0K Buy | Form 4 ↗ |
| Jan 15, 2026 | Thomas J. Schall Director | IMRX Immuneering Corporation | Buy | 21,645 | $4.67 | $101.1K Buy | Form 4 ↗ |
| Jan 15, 2026 | Brett Matthew Hall CHIEF SCIENTIFIC OFFICER | IMRX Immuneering Corporation | Buy | 2,298 | $4.57 | $10.5K Buy | Form 4 ↗ |
| Jan 13, 2026 | Leah R. Neufeld CHIEF PEOPLE OFFICER | IMRX Immuneering Corporation | Buy | 2,626 | $4.15 | $10.9K Buy | Form 4 ↗ |
| Jan 12, 2026 | Peter Feinberg Director | IMRX Immuneering Corporation | Buy | 20,000 | $4.35 | $87.0K Buy | Form 4 ↗ |
| Oct 3, 2025 | Peter Feinberg Director | IMRX Immuneering Corporation | Buy | 7,500 | $6.67 | $50.0K Buy | Form 4 ↗ |
| Oct 1, 2025 | Mallory Morales Chief Accounting Officer | IMRX Immuneering Corporation | Buy | 300 | $6.39 | $1,917 Buy | Form 4 ↗ |
| Oct 1, 2025 | Leah R. Neufeld CHIEF PEOPLE OFFICER | IMRX Immuneering Corporation | Buy | 800 | $6.38 | $5,104 Buy | Form 4 ↗ |
| Oct 1, 2025 | Michael Bookman CHIEF LEGAL OFFICER, SECRETARY | IMRX Immuneering Corporation | Buy | 1,020 | $6.83 | $6,967 Buy | Form 4 ↗ |
| Sep 30, 2025 | Peter Feinberg Director | IMRX Immuneering Corporation | Buy | 7,500 | $7.03 | $52.7K Buy | Form 4 ↗ |
| Sep 29, 2025 | Peter Feinberg Director | IMRX Immuneering Corporation | Buy | 5,000 | $7.18 | $35.9K Buy | Form 4 ↗ |
| Jul 2, 2025 | Diana Hausman Director | IMRX Immuneering Corporation | Buy | 3,000 | $3.62 | $10.9K Buy | Form 4 ↗ |
| Jul 2, 2025 | Diana Hausman Director | IMRX Immuneering Corporation | Buy | 2,500 | $3.60 | $9,000 Buy | Form 4 ↗ |
| Jul 2, 2025 | Leah R. Neufeld CHIEF PEOPLE OFFICER | IMRX Immuneering Corporation | Buy | 700 | $3.57 | $2,499 Buy | Form 4 ↗ |
| Jul 2, 2025 | Benjamin J. Zeskind PRESIDENT AND CEO, Director, 10% owner | IMRX Immuneering Corporation | Buy | 7,015 | $3.53 | $24.8K Buy | Form 4 ↗ |
| Jul 1, 2025 | Benjamin J. Zeskind PRESIDENT AND CEO, Director, 10% owner | IMRX Immuneering Corporation | Buy | 2,985 | $3.38 | $10.1K Buy | Form 4 ↗ |
| Jun 27, 2025 | Thomas J. Schall Director | IMRX Immuneering Corporation | Buy | 9,500 | $3.66 | $34.8K Buy | Form 4 ↗ |
| Jun 23, 2025 | Brett Matthew Hall CHIEF SCIENTIFIC OFFICER | IMRX Immuneering Corporation | Buy | 6,007 | $2.43 | $14.6K Buy | Form 4 ↗ |
| Jun 20, 2025 | Brett Matthew Hall CHIEF SCIENTIFIC OFFICER | IMRX Immuneering Corporation | Buy | 7,415 | $2.70 | $20.0K Buy | Form 4 ↗ |
| Jun 20, 2025 | Harold Eugene Brakewood Chief Business Officer | IMRX Immuneering Corporation | Buy | 1,900 | $2.53 | $4,807 Buy | Form 4 ↗ |
| Jun 18, 2025 | Peter Feinberg Director | IMRX Immuneering Corporation | Buy | 25,000 | $2.53 | $63.3K Buy | Form 4 ↗ |
| Jun 18, 2025 | Benjamin J. Zeskind PRESIDENT AND CEO, Director, 10% owner | IMRX Immuneering Corporation | Buy | 21,000 | $2.39 | $50.2K Buy | Form 4 ↗ |
| Jun 17, 2025 | Thomas J. Schall Director | IMRX Immuneering Corporation | Buy | 40,485 | $2.21 | $89.5K Buy | Form 4 ↗ |
25 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:54 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances